0000000000501314

AUTHOR

Filippo Flavio Angileri

showing 6 related works from this author

Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic…

2010

Summary Introduction Post-neurosurgical nosocomial meningitis has become an important subgroup of bacterial meningitis in the hospital setting. The increase in meningitis caused by multidrug-resistant (MDR) Acinetobacter baumannii has resulted in a significant reduction in available treatment options. Case report and literature review We report the case of a 36-year-old man with a complex craniofacial trauma, who developed a nosocomial meningitis due to MDR A. baumannii that was cured by intrathecal colistin. The case is contextualized among all the published cases of Acinetobacter meningitis treated with topical colistin found through a MEDLINE search of the literature. To date, including …

Microbiology (medical)Acinetobacter baumanniiAdultMalemedicine.medical_specialtymedicine.drug_classIntraventricularAntibioticsNeurosurgeryIntrathecalMeningitis BacterialPharmacotherapyPostoperative ComplicationsInternal medicineDrug Resistance Multiple BacterialMedicineCraniocerebral TraumaHumansMeningitisInjections SpinalbiologyAcinetobacterbusiness.industryColistinAcinetobacter; Colistin; Intrathecal; Intraventricular; Meningitis; NeurosurgeryGeneral MedicineAcinetobacterbiochemical phenomena metabolism and nutritionbiology.organism_classificationmedicine.diseaseSurgeryAcinetobacter baumanniiAnti-Bacterial AgentsMultiple drug resistanceMeningitiInfectious DiseasesTreatment OutcomeColistinNeurosurgerybusinessMeningitismedicine.drugAcinetobacter Infections
researchProduct

Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix.

2012

Purpose: This study investigated the absorption mechanism of the phytochemicals indicaxanthin and betanin and the influence of their food matrix (cactus pear and red beet) on the intestinal transport. Methods: Trans-epithelial transport of dietary-consistent amounts of indicaxanthin and betanin in Caco-2 cell monolayers seeded on TranswellR inserts was measured in apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction, under an inwardly directed pH gradient (pH 6.0/7.4, AP/BL) mimicking luminal and serosal sides of human intestinal epithelium. The effect of inhibitors of membrane transporters on the absorption was also evaluated. Contribution of the paracellular route was…

Absorption (pharmacology)Cell Membrane PermeabilityChemical PhenomenaPyridinesBetalainsindicaxanthinMedicine (miscellaneous)Plant RootsIntestinal absorptionAntioxidantsCaco-2 cellchemistry.chemical_compoundPigmentSettore BIO/10 - BiochimicaHumansbetalains;intestinal absorption; Caco-2 cells; betalainic food; indicaxanthin; betaninFood scienceIntestinal MucosaBetaninbetalainic foodPEARNutrition and DieteticsbetaninbetalainCell PolarityFood Coloring AgentsOpuntiaBiological TransportPigments BiologicalBetaxanthinsIntercellular JunctionschemistryIntestinal AbsorptionCaco-2visual_artFruitFood Fortifiedvisual_art.visual_art_mediumATP-Binding Cassette TransportersDigestionBetacyaninsBeta vulgarisCaco-2 CellsDigestionIndicaxanthinEuropean journal of nutrition
researchProduct

Fibrin Sealants in Dura Sealing: A Systematic Literature Review.

2016

BACKGROUND:Fibrin sealants are widely used in neurosurgery to seal the suture line, provide watertight closure, and prevent cerebrospinal fluid leaks. The aim of this systematic review is to summarize the current efficacy and safety literature of fibrin sealants in dura sealing and the prevention/treatment of cerebrospinal fluid leaks. METHODS:A comprehensive electronic literature search was run in the following databases: Cochrane Database of Systematic Reviews, Cochrane Central Resister of Controlled Trials, clinicaltrials.gov, MEDLINE/PubMed, and EMBASE. Titles and abstracts of potential articles of interest were reviewed independently by 3 of the authors. RESULTS:A total of 1006 databas…

Genetics and Molecular Biology (all)Dura materCerebrospinal Fluid Leak Collagen-only biomatrix Transsphenoidal surgery Allergic reaction Mater substitute Tissue adhesive Sellar repair Glue Prevention Managementlcsh:MedicineFibrin Tissue AdhesiveBiochemistryNeurosurgical Procedureslaw.inventionCerebrospinal Fluid Leak; Dura Mater; Fibrin; Fibrin Tissue Adhesive; Humans; Neurosurgical Procedures; Postoperative Complications; Postoperative Period; Prospective Studies; Resins Synthetic; Retrospective Studies; Tissue Adhesives; Medicine (all); Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)0302 clinical medicinePostoperative ComplicationsRandomized controlled triallawPostoperative PeriodProspective Studieslcsh:ScienceMultidisciplinarybiologyCerebrospinal fluid leakCerebrospinal Fluid LeakMedicine (all)Resins Syntheticmedicine.anatomical_structureSystematic review030220 oncology & carcinogenesisResinsmedicine.medical_specialtyFibrin Tissue AdhesiveFibrin03 medical and health sciencesmedicineHumansRetrospective StudiesFibrinBiochemistry Genetics and Molecular Biology (all)business.industrySealantlcsh:RSyntheticCorrectionmedicine.diseaseSurgeryClinical trialAgricultural and Biological Sciences (all)biology.proteinlcsh:QTissue AdhesivesDura Materbusiness030217 neurology & neurosurgeryPloS one
researchProduct

Giant olfactory groove meningiomas: extent of frontal lobes damage and long-term outcome after the pterional approach.

2010

The treatment of giant olfactory groove meningiomas (OGMs; maximum diameter ≥ 6 cm) poses special problems and represents a surgical challenge. We discuss the long-term results in a series of 18 patients with giant OGMs and report our experience on a global strategy encompassing the pterional approach to manage the lesion and an extended transbasal approach to treat recurrences.Between February 1991 and December 2007, 18 patients with giant OGMs were surgically managed via a pterional craniotomy. Postoperative follow-up imaging was obtained at one, six, and 12 months and then yearly. In preoperative images, data from tumor volume were assessed. The volume of the residual right frontal poren…

AdultMaleMicrosurgerymedicine.medical_specialtymedicine.medical_treatmentFluid-attenuated inversion recoveryNeurosurgical ProceduresMeningiomaOlfactory groovePterional approachLesionMeningiomaPostoperative ComplicationsOlfactory Groove MeningiomamedicineHumansOlfactory GrooveAgedmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingOlfactory PathwaysMiddle AgedMicrosurgeryNeurovascular bundlemedicine.diseaseLong-Term CareMagnetic Resonance ImagingFrontal LobeSurgeryTreatment OutcomeFemaleSurgeryNeurology (clinical)medicine.symptomMeningiomaTomography X-Ray ComputedbusinessFollow-Up Studies
researchProduct

Expression of the tumor necrosis factor receptor—associated factors 1 and 2 and regulation of the nuclear factor—kB antiapoptotic activity in human g…

2005

Object. Tumor necrosis factor receptor (TNFR)—associated factors (TRAFs) are a recently established group of proteins involved in the intracellular signaling of the TNFR superfamily members. The TRAFs have been implicated in promoting cell survival through the activation of transcription factor nuclear factor (NF)—κB. The authors investigated the expression of NF-κB, caspase 3, TRAF1, TRAF2, and TRAF-associated NF-κB activator/TRAF—interacting protein (TANK/I-TRAF), a regulator of TRAF activity, in human gliomas. Methods. Tumor samples were obtained in 27 adult patients harboring seven low-grade gliomas, nine anaplastic astrocytomas, and 11 glioblastomas multiforme. The NF-κB activation was…

AdultMalePathologymedicine.medical_specialtyBlotting WesternTRAF1Apoptosis Blotting Brain Neoplasms/metabolism Brain Neoplasms/pathology Caspase GliomaApoptosisCaspase 3BiologyGliomamedicineHumansTranscription factorAgedAged 80 and overTankyrasesBrain NeoplasmsCaspase 3NF-kappa BGliomaMiddle AgedTNF Receptor-Associated Factor 2medicine.diseaseTNF Receptor-Associated Factor 1Up-RegulationIntracellular signal transductionBlotTumor Necrosis Factor Receptor-Associated FactorsCaspasesCancer researchFemaleTumor necrosis factor alphaSignal TransductionJournal of Neurosurgery
researchProduct

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhag…

2007

Increased levels of glutamate and aspartate have been detected after subarachnoid hemorrhage (SAH) that correlate with neurological status. The NMDA receptor antagonist felbamate (FBM; 2-phenyl-1,3-propanediol dicarbamate) is an anti-epileptic drug that elicits neuroprotective effects in different experimental models of hypoxia-ischemia. The aim of this dose-response study was to evaluate the effect of FBM after experimental SAH in rats on (1) behavioral deficits (employing a battery of assessment tasks days 1-5 post-injury) and (2) blood-brain barrier (BBB) permeability changes (quantifying microvascular alterations according to the extravasation of protein-bound Evans Blue by a spectropho…

Malemedicine.medical_specialtyExcitotoxicityPhenylcarbamatesBehavioral deficitsmedicine.disease_causeCisterna magnaBlood–brain barrierNeuroprotectionReceptors N-Methyl-D-AspartateFelbamateRats Sprague-Dawleychemistry.chemical_compoundInternal medicinemedicineAnimalsAnimals; Blood-Brain Barrier; Rats; Subarachnoid Hemorrhage; Evans Blue; Behavioral deficits; Cognitive deficits; NMDA receptor; FelbamatePostural BalanceEvans BlueBehavior AnimalDose-Response Relationship Drugbusiness.industryCognitive deficitsMicrocirculationBody WeightGlutamate receptorSubarachnoid HemorrhageNMDA receptorFelbamateRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsSpectrometry FluorescencechemistryBlood-Brain BarrierPropylene GlycolsAnesthesiaCerebrovascular CirculationNMDA receptorNeurology (clinical)businessmedicine.drugEvans BlueJournal of neurotrauma
researchProduct